Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-69.28%Return on Equity
VS
Market
Sector
Industry
History
$ 6.33Close
$ 2.3 - $ 10.36 52-Week Range
Ticker Information
Ticker
XBIOCompany Name
XENETIC BIOSCIENCES INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQXENETIC BIOSCIENCES INC - Return on Equity Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
XBIO - ROE Historical data
| Date | Shareholders Equity | Net Income Common Stock | Return on Equity |
|---|---|---|---|
| 6/30/2025 | $ 4.45M | $ -3.08M | -69.28% |
| 3/31/2025 | $ 5.12M | $ -3.67M | -71.6% |
| 12/31/2024 | $ 6.01M | $ -3.96M | -65.93% |
| 9/30/2024 | $ 7.04M | $ -4.08M | -57.94% |
| 6/30/2024 | $ 7.45M | $ -4.7M | -63.07% |
| 3/31/2024 | $ 8.68M | $ -4.47M | -51.55% |
| 12/31/2023 | $ 9.8M | $ -4.13M | -42.21% |
| 9/30/2023 | $ 10.89M | $ -4.45M | -40.81% |
| 6/30/2023 | $ 11.88M | $ -4.19M | -35.31% |
| 3/31/2023 | $ 12.86M | $ -5.82M | -45.22% |
Key Performance Insights, Last 5 Years
- XENETIC BIOSCIENCES INC's latest trailing twelve months (TTM) ROE stands at -137.38%.
- Over the past 5 years, XENETIC BIOSCIENCES INC's average ROE has been -60.91%.
- The median ROE for XENETIC BIOSCIENCES INC during this period was -50.33%
- XENETIC BIOSCIENCES INC reached its highest ROE over the past 5 years at -24.81%.
- The lowest ROE recorded by XENETIC BIOSCIENCES INC in the same timeframe -137.38%
XENETIC BIOSCIENCES INC's ROE vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
ROE Benchmarks
Similar metrics to ROE:
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Return on Assets - [Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Return on Invested Capital - [Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
Definition of Return on Equity
[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].Net Inc. Cmn. / Equity
(=) ROE ROE for XENETIC BIOSCIENCES INC is calculated as follows: Net Inc. Cmn. [ $ -10.86M ] / Equity [ $ 7.91M ]
(=) ROE [ -137.38% ] XBIO - Return on Equity, Last 5 years
-137.38%
Minimum
Sep 30, 2020
-24.81%
Maximum
Sep 30, 2021
-60.91%
Average
-50.33%
Median
ROE Benchmark AnalysisMarket
The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.63% with a standard deviation of 22.52%.
The following table provides additional summary stats:
ROE in the Market:
| filtered constituents | 3.13K |
|---|---|
| min | -66.24% |
| max | 73.25% |
| average | 1.63% |
| median | 6.53% |
| std | 22.52% |